DelSite Signs Agreement With Global Pharmaceutical Firm for GelSite Polymer
Posted on: Wednesday, 16 April 2008, 09:01 CDT
Carrington Laboratories has announced that its wholly-owned subsidiary, DelSite Biotechnologies, has entered into a non-exclusive technology evaluation agreement with a global pharmaceutical company for evaluating DelSite's GelSite polymer-based delivery technologies.
The goal of the program is to evaluate DelSite's parenteral technologies. DelSite has also agreed to provide GelSite polymer and technical information concerning the optimal solubilization and mixing conditions.
GelSite polymer is a novel, naturally-occurring ionic carbohydrate polymer that is capable of forming a gel upon contact with body fluids. DelSite has also completed a series of toxicology studies on GelSite polymer and the delivery platforms.
Carlton Turner, president and CEO of Carrington Laboratories and DelSite Biotechnologies, said: "DelSite's technologies are novel and patent-protected, and we are dedicated to developing them for a wide range of applications. This agreement represents another highlight of increased interest in DelSite's technologies within the pharmaceutical industry."
Source: Datamonitor
Related Articles
- Dow Kokam Acquires the Assets of Kokam America
- Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
- Lux Biosciences' Presentations at ARVO Highlight Both Topical and Polymer Delivery Technologies Targeting Chronic Inflammatory Ocular Diseases
- Link Plus Forms Subsidiary to Develop MIPs-Based Solutions for Detection and Filtering of Viruses for Public Health Applications
- DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
- Carrington's DelSite Drug Delivery Technology Platforms Highlighted at Rodman & Renshaw Investor Conference
- DelSite Licenses NIH Technology to Develop Typhoid Vaccine
- Carrington Laboratories to Manufacture Sublingual Vaccines
- DelSite Licenses Technology for HIV Vaccine
- Celanese Names Univar As Distributor for Mowilith(R) and Vinamul(R) Emulsions; New Relationship Positions Distributor to Provide Leading-Edge Polymer Emulsion Technology in Western European Countries
 |
 |
User Comments (0)
RSS Feeds